Stanford Investment Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-21
| Closed | – | – | 376 |
|
|
2016
Q4 | $0 | Hold |
21
| – | – | ﹤0.01% | 434 |
|
|
2016
Q3 | $0 | Hold |
21
| – | – | ﹤0.01% | 423 |
|
|
2016
Q2 | $0 | Hold |
21
| – | – | ﹤0.01% | 373 |
|
|
2016
Q1 | $0 | Hold |
21
| – | – | ﹤0.01% | 377 |
|
|
2015
Q4 | $0 | Hold |
21
| – | – | ﹤0.01% | 364 |
|
|
2015
Q3 | $0 | Hold |
21
| – | – | ﹤0.01% | 374 |
|
|
2015
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 343 |
|
|
2015
Q1 | $2K | Hold |
21
| – | – | ﹤0.01% | 338 |
|
|
2014
Q4 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 343 |
|